Sleep Disorders
Telehealth and cognitive behavioral therapy for insomnia (CBT-I)
Dec. 03, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Sleep paralysis …
- Updated 09.12.2024
- Released 02.13.1995
- Expires For CME 09.12.2027
Sleep paralysis
Introduction
Overview
In this article, the author details the clinical and laboratory features of sleep paralysis, an intriguing REM sleep-related parasomnia found in a relevant number of otherwise normal subjects and associated but not coincidental with narcolepsy-cataplexy. Sleep paralysis may be familial and is thought to represent a disorder of REM sleep, whereby muscle atonia typical of REM sleep is concomitant with a wakeful conscious experience. The hallucinations of sleep paralysis seem to revolve around a core experience of “sensed presence” consistent with the hypothesis of REM sleep initiation of a threat-activated vigilance system.
Key points
|
• Sleep paralysis is a REM sleep parasomnia characterized by an inability to perform voluntary movements associated with marked anxiety that occurs either at sleep onset (hypnagogic form) or on awakening (hypnopompic form). | |
|
• Sleep paralysis attacks last a few minutes, do not involve respiratory and ocular muscles, are fully reversible, and often are accompanied by terrifying hallucinatory phenomena. | |
|
• Sleep paralysis may form part of the narcoleptic tetrad, but isolated sleep paralysis occurs independently of narcolepsy, sometimes in a familial form. |
Historical note and terminology
Sleep paralysis was first described in 1876 by Mitchell, who termed it "night palsy" (30); the term "sleep paralysis" was introduced by Wilson in 1928. Earlier descriptions are, however, found in the “modern” medical literature, such as the one by the Dutch physician Isbrand van Diemerbroeck in 1664 (24), as well as in the “ancient” medical literature, such as that from the Persian Akhawayni in his Hidayat al-muta’allemin fi al-tibb (Learner’s guide to medicine) compiled in the 10th century and others from the ancient Chinese and Greek culture (16). Literary descriptions of sleep paralysis can also be found in “The Horla” by Guy De Maupassant, in the novel Moby Dick by Herman Melville (29), in The Brothers Karamazov by Fyodor Dostoyevsky (43), and in Nikolai Gogol's tale "The Portrait" (01). Other names in English used to describe sleep paralysis include "nocturnal paralysis," "cataplexy of awakening," "hypnagogic and hypnopompic paralysis," and "predormital and postdormital paralysis"; in French it has been termed cataplexie du réveil. Furthermore, "Old Hag" in Canada, kanashibari in Japan, "ghost oppression" in Hong Kong Chinese, and ogun oru in Nigerian are colloquial terms employed by patients and reflect popular credence of sleep paralysis as witchcraft possession and paranormal experiences, very relevant to the issue of transcultural psychiatry (10). Moreover, the endorsement of a supernatural causal explanation of sleep paralysis is highly influenced by cultural and educational background, which can profoundly shape certain aspects of the experience during the episodes (21).
Adie and Wilson, in the 1920s, noted that sleep paralysis occurs frequently in patients with narcolepsy. When sleep paralysis occurs independently of narcolepsy and other medical conditions, it is termed “isolated” sleep paralysis. The more specific diagnostic syndrome of “recurrent isolated sleep paralysis,” classified in the current International Classification of Sleep Disorders within REM related parasomnias (02), is defined when sleep paralysis causes clinically significant distress including bedtime anxiety or fear of sleep.
Clinical manifestations
Presentation and course
Sleep paralysis is characterized by a brief period of inability to perform voluntary movements occurring at sleep onset (hypnagogic or predormital form) or when awakening, either during the night or in the morning (hypnopompic or postdormital form). Isolated sleep paralysis frequently occurs when awakening (in 64% of patients), whereas in narcolepsy and familial sleep paralysis, the episodes are more frequent at sleep onset. Spontaneous sleep paralysis episodes showed a skewed distribution over the night, with one quarter of episodes occurring within one hour of bedtime, although episodes were reported throughout the night with a minor mode around the time of normal waking.
Typically during sleep paralysis, patients are powerless to move the head, trunk, and limbs as well as to speak and even open the eyes, although ocular and respiratory movements are intact. A tingling sensation is common. Sometimes, patients feel unable to breathe deeply and have a feeling of suffocation frequently related to the sensation of a being that exerts pressure on the thorax (31; 08). The episodes can be preceded by an “aura” with auditory, tactile, or visual perceptions (18). During sleep paralysis, the patient is fully awake or half awake, the sensorium is clear, awareness of surroundings and self is fairly well-preserved, and patients are able to recall the sleep paralysis afterward. During sleep paralysis, patients usually engage in a mental struggle to cry out and to move, yet they appear to be in deep sleep or dreaming. Many episodes of sleep paralysis, especially the first to take place in a patient's life, cause extreme anxiety associated with fear of dying during the episode. This anxiety is greatly intensified by terrifying dreamlike images or hallucinations (hypnagogic or hypnopompic hallucinations). Pleasant sensations during the episodes are less frequent (23) and usually associated with out of body experiences (18). Women report experiencing more phenomena and emotions, and more fearful emotions than men (especially the fear of going crazy), and are more likely to perceive concrete forms such as human figures or people they know (27).
In a study on 185 patients with isolated sleep paralysis who underwent a clinical interview, 57% reported to sense a presence in the room, usually a nonhuman presence (42). In addition, 21% of the sample experienced visual hallucinations of others, with the majority perceiving strangers as opposed to known individuals.
Sleep paralysis is transient, lasting only one to several minutes (average duration of episodes: 4 minutes) and disappearing either spontaneously or on external stimulation, especially by simple touch or movement induced by another person. Some patients note that repeated efforts to move the body or make vigorous eye movements may help to abort a paralytic episode. Patients may sometimes relapse into sleep paralysis if they remain supine; indeed, sleep paralysis has been shown to occur predominantly with the patient sleeping in the supine position. Both body position and timing of the sleep paralysis episodes were found to affect incidence and, to a lesser extent, quality of the sleep paralysis experience. Patients may also fail to establish the boundaries between real experience and dream mentation during the paralysis, suggesting a dissociated state of mind between wakefulness and REM sleep (45).
Once ended, sleep paralysis leaves no sequelae. Neurologic examination is normal. On rare occasions, some weakness or numbness in the extremities remains for a few minutes.
The current International Classification of Sleep Disorders (02) cites the following:
|
The patient complains of: | |
|
(A) A recurrent inability to move the trunk and all limbs at sleep onset or upon awakening from sleep. | |
|
(B) Each episode lasts seconds to a few minutes. | |
|
(C) The episodes cause clinically significant distress including bedtime anxiety or fear of sleep. | |
|
(D) The disturbance is not better explained by another sleep disorder (particularly narcolepsy), mental disorder, medical condition, medication, or substance use. | |
|
Of note: | |
|
Hallucinatory experiences may be present but are not essential to the diagnosis. Polysomnography, if performed, reveals whether the event occurs in a dissociated state with elements of REM sleep and wakefulness. | |
Prognosis and complications
No studies have demonstrated any long-term consequences on the health of patients who experience sleep paralysis. Although the underlying risk factors may contribute to health-related issues later in life (for example, anxiety poses a risk for hypertension), there is no reported independent association (15).
Isolated sleep paralysis is associated with shorter sleep duration, longer sleep-onset latency, worse sleep quality, and evening chronotypes (37; 08).
Even if episodes are frequent, no sequelae or serious effects on the life of patients are presented, with a normal state returning between episodes (12).
Sleep paralysis peak onset is between 17 and 19 years of age, with no sex difference (47). Episodes become less frequent with age, often with spontaneous remissions and relapses.
Clinical vignette
A 31-year-old male without relevant family history reported onset at 13 years of age of frightening episodes during which he was unable to move, speak, and even open his eyes. Episodes occurred first during naps and then during nocturnal sleep. During such episodes, he remained conscious and well in contact with the environment. He reported no dreaming or hallucinatory activity. The episodes lasted a few minutes and had a frequency of two to three times per night every night for the initial two years. There followed a spontaneous improvement until 22 years of age, when the frequency of the attacks returned to previous levels. The patient also reported recurrent nocturnal obsessive thoughts concerning his work and daily activities and increased perspiration. Frequency again decreased to one episode every 2 to 3 months until 28 years of age; the patient was now able to ask for help during the episodes. Immediately before admission, however, episodes recurred in clusters with free periods of up to 7 to 10 days. The patient felt tired and had tension-type headache but had never noticed sleep or drop attacks during the daytime. Neurologic examination and brain MRI were normal. Human leukocyte antigen typing was positive for the DRB1 01 and 0701, and DQB1 05 and 03032 antigens, not typically associated with narcolepsy. A night polysomnographic recording showed normal hypnic patterns and normal REM sleep duration and latency. The first REM episode was, however, associated with a lack of physiological atonia in chin muscles, and stages 2 of NREM sleep were characterized by several periods lasting 10 to 20 seconds, with diffuse alpha EEG activity and antigravitational muscle atonia. Mild snoring in the supine position was not associated with changes in arterial oxygen saturation. The physiological recordings ran for 48 hours; meanwhile, the patient suffered four nocturnal episodes of his typical "paralysis," all arising during REM sleep and with diffuse alpha mixed to theta EEG activity and atonia of chin muscles.
A multiple sleep latency test showed a normal sleep latency of 20' and no diurnal sleepiness. A diagnosis of isolated sleep paralysis was made.
Biological basis
Etiology and pathogenesis
The etiology of isolated recurrent sleep paralysis is unknown. Sleep paralysis may be found in families and occurs frequently as one of the classic symptoms of narcolepsy. The involvement of the hypocretin system has been proved in canine and murine narcolepsy and decreased or absent hypocretin levels have been found in the CSF of humans with narcolepsy. Hypocretins (also called orexins) are neuropeptides localized in synaptic vesicles in the hypothalamus that exert wake-promoting and REM sleep suppressant effects interacting with the aminergic and cholinergic systems. The hypocretin system projects densely from the lateral hypothalamus to the locus coeruleus, and hypocretin administration increases neuronal discharges in the locus coeruleus. Activity in the locus coeruleus ceases before and during cataplectic attacks, and locus coeruleus discharges are scant in narcoleptic dogs. Thus, deficient hypocretin pathways may remove excitation from the locus coeruleus, increasing the propensity for cataplexy and possibly sleep paralysis. However, no studies of hypocretins in isolated sleep paralysis have been executed; therefore, the relationship between isolated sleep paralysis and hypocretins remains unknown, and no association with human leukocyte antigens has been found differently from narcolepsy.
In a study on 16 normal subjects, polysomnogram recordings showed a REM/wake stage dissociated state during sleep paralysis (abundant alpha electroencephalographs and persistence of muscle atonia shown by the tonic electromyogram) (44). For this reason, sleep paralysis has been considered a condition characterized by a pathological dissociation between the level of alertness/self-awareness typical of wakefulness and the generalized muscle atonia typical of REM sleep. These abnormalities are probably attended by hyperactivity of cholinergic mechanisms in pontine or suprapontine neuronal structures as well as deficits in noradrenergic or serotonergic mechanisms in the brainstem that exert a gating influence on the cholinergic neurons responsible for muscle atonia during REM sleep. Dimensional MRI measurements revealed a statistically significant increase in the antero-posterior diameter of the midbrain-pons junction and cerebellar vermis height in people with recurrent isolated sleep paralysis (28). This increase could be a sign of an over-compensatory mechanism to dysfunctional regulatory pathways.
EEG studies on people with narcolepsy showed, with spectral analysis, that sleep paralysis is associated with EEG features typical of REM sleep (not of wakefulness), including mainly theta rhythms and occasional bursts of alpha rhythms (concomitant with rapid eye movements) as well as muscle atonia. Consequently, the concept of sleep paralysis as an awake brain in a paralyzed body has been reviewed in favor of a rather partially aware but dreaming state (45; 26).
Spectral analysis (on all sleep stages in the delta, theta, and alpha band) showed a significantly higher power of theta band activity in REM and NREM2 sleep stages in patients with recurrent isolated sleep paralysis (06). The observed rise was also apparent in other sleep stages. Conversely, alpha power showed a downward trend. Furthermore, patients showed significant differences in the temporal dynamics of the EEG microstate, suggesting that in order to understand the neurobiological background of sleep paralysis, there is a need to extend the analyses beyond REM-related processes.
From a neuropsychological perspective, sleep paralysis hallucinations have been shown to revolve around a core experience of “sensed or felt presence,” consistent with the hypothesis of REM sleep initiation of a threat-activated vigilance system. Among the varied hallucinations associated with sleep paralysis, out-of-body experiences and vestibular-motor sensations represent a distinct factor. The results of self-report data from two online surveys of sleep paralysis were interpreted as consistent with the hypothesis that out-of-body experiences represent a breakdown in the normal binding of bodily-self sensations, suggesting that out-of-body feelings are consequences of anomalous vestibular motor experiences and precursors to a particular form of autoscopic experience, out-of-body autoscopy (07). The same “disintegration model” phenomenology (illusory movement experience, out-of-body feelings, out-of-body autoscopy) has been documented in recreational ketamine users, supporting a potential temporal-parietal dysfunctional interaction induced either by REM sleep or by substance abuse. The occurrence of dissociative experiences during wakefulness may link sleep paralysis and lucid dreaming occurrence in otherwise healthy subjects (13).
Epidemiology
Surveys of normal subjects indicate that isolated sleep paralysis occurs at least once in a lifetime in a substantial proportion of otherwise normal subjects.
The prevalence of sleep paralysis varies from countries and ethnic groups, and this disparity has been linked to different methodologies in determining the prevalence, including the different definitions of sleep paralysis (35).
Prevalence and incidence of the disorder are predicted by age, race, major depressive disorder, pain, hypersomnolence, cataplexy, hypnagogic and hypnopompic hallucinations, posttraumatic stress disorder, a reduction in sleep duration of 60 or more minutes, and the use of analgesic or antipyretic medication (33).
In a systematic literature review aggregating 36,533 subjects across different studies, 7.6% of the general population, 28.3% of students, and 31.9% of psychiatric patients reported at least one sleep paralysis event (40).
In a sleep survey of 8162 citizens, the cumulative experience of sleep paralysis was 39.6%, with the onset peaking at 16 years of age (25). However, Ohayon and colleagues found strikingly lower rates: 6.2% of 494 otherwise normal subjects reported at least one episode of isolated sleep paralysis in their lifetime, with 4% reporting less than one episode per month and 0.8% more than one per week (34). Using International Classification of Sleep Disorders criteria, 2.7% had sleep paralysis at least once per week, 18.2% once per month, and 75.5% less than once per month.
Fourteen percent of Nigerian young adults reported sleep paralysis.
Prevalence rates among students from various universities ranges from 30% to 40% (03; 14), with a peak onset between 17 and 19 years of age and higher prevalence in women (32).
In many patients with narcolepsy, sleep paralysis occurs every night in some periods of life but becomes much less frequent in other times of life.
Approximately 41% of patients with narcolepsy frequently suffer from sleep paralysis, which is sometimes associated with rhythmic movement disorder as motor manifestation of the attempt to "shake out" of the paralysis (36). The prevalence of sleep paralysis ranges from 25% to 74% in patients with narcolepsy type 1, and its progressive appearance along the narcolepsy course suggests it may be an age-dependent phenomenon (38).
Prevention
Sleep paralysis is frequently associated with narcolepsy and may occur in other conditions characterized by disturbed nocturnal sleep and wake-sleep rhythm. Age, BMI, smoking, alcohol consumption, sleep duration, and perceived stress are all factors modulating the incidence and severity of the disorder (48). In general, irregular sleep habits, sleep deprivation, disturbed sleep-wake rhythm, psychological stress, overtiredness, and sleeping in the supine position have been considered predisposing factors and should be avoided. Isolated sleep paralysis is frequent among night-shift workers (ie, nurses, associated with insomnia) (25) and in jet lag syndrome. Sleep paralysis may even be purposefully elicited by sleep interruption in normal subjects, especially in subjects with a low tolerance for disrupted sleep-wake rhythms in whom it appears to occur as a phenotype of REM dissociation during sleep onset REM periods.
Differential diagnosis
Confusing conditions
In general, the features of sleep paralysis are sufficiently clear, and the diagnosis is not difficult. The inter-observer reliability of the former International Classification of Sleep Disorders minimal diagnostic criteria for sleep paralysis was also found substantial, with a kappa value of 0.69 (range 0 to 1, ie, maximum agreement).
Isolated and familial sleep paralysis can be readily distinguished from narcolepsy, in which excessive daytime sleepiness, cataplexy, and vivid hypnagogic hallucinations frequently occur along with sleep paralysis. Cataplexy is differentiated by its occurrence in the waking state, rather than in sleep-wake transitions in the lying position, as well as by its precipitation by strong, mainly positive emotions.
Nightmares are REM-based parasomnias that can be confused for sleep paralysis for the associated hallucinations and dream imagery. The conscious awareness of one’s surroundings and atonia is missing in nightmares.
Atonic generalized epileptic seizures can be differentiated by their usual occurrence in the daytime waking state and by their epileptic EEG abnormalities.
Atonic drop attacks in patients with vertebrobasilar vascular insufficiency or in those with moyamoya disease usually occur in the waking state, are often accompanied by transient clouding of consciousness or unconsciousness and are not related to sleep-wake transitions in bed.
Hypokalemic periodic paralysis often occurs on awakening but lasts hours or even days; patients cannot be so easily and promptly relieved of the motor paralysis by touching or moving their bodies. Hypokalemic periodic paralysis, which shows low serum potassium levels during attacks, may be provoked by high carbohydrate meals or alcohol and is readily reversed by correcting the hypokalemia.
Hysterical paralysis and catatonia must be distinguished but are usually evident by their associated clinical features. Occasionally, the dramatic symptoms associated with sleep paralysis may be mistaken for a psychotic state.
Nocturnal panic attacks such as sleep paralysis are both characterized by fear and acute distress. Nocturnal panic attacks lack paralysis and dream imagery and are unexpected, acute, and scary, whereas fear in sleep paralysis is often secondary to the paralysis/hallucinations (39).
The sensory features of sleep paralysis are mimicked by those of peduncular hallucinosis, a condition characterized by formed and colored visual images, which the patient knows are unreal, associated with lesions of the pons, midbrain, and diencephalon. Peduncular hallucinosis, however, lacks the motor features typical of sleep paralysis (46).
Associated or underlying disorders
Sleep paralysis is frequently associated with narcolepsy (41% of patients with narcolepsy suffer from this disorder). For this reason, sleep palsy is included in the "narcoleptic tetrad" together with sleep attacks, cataplexy, and hypnagogic hallucinations, but they are rarely the first symptom of narcolepsy (05). Further sleep disorders associated with sleep palsies are insomnia, obstructive sleep apnea, idiopathic hypersomnia, hypnopompic hallucinations, nocturnal leg cramps, and nightmares (11).
Psychiatric comorbidity has been associated with sleep paralysis, in particular posttraumatic stress disorder. Furthermore, panic disorder, generalized anxiety disorder, death anxiety, and social anxiety are frequent symptomatic accompaniments to sleep palsies (39).
Other associated disorders are generalized epilepsy, multiple sclerosis, automatic behaviors, and physical disease (34; 09).
Isolated sleep paralysis is often associated with substance use, stress, and trauma, in particular trauma related to bereavement (04), as well as genetic influences, physical illness, personality, intelligence, anomalous beliefs, symptoms of psychiatric illness in nonclinical samples (particularly anxiety symptoms), and psychiatric disorders (12).
Sleep paralysis and cataplexy occur more often in patients affected with Wilson disease. Patients with myotonic dystrophy type 1 with subjective sleepiness also reported more cataplexy-like and sleep paralysis symptoms.
Diagnostic workup
Sleep palsy diagnosis is mainly clinical. An accurate clinical history is essential to exclude other disorders associated with sleep paralysis such as narcolepsy. The Unusual Sleep Experiences Questionnaire was developed to assess the subjective phenomenology of during the episodes.
Polysomnographic recordings under audiovisual control may be useful in the diagnosis of sleep paralysis and should be entertained whenever attacks are frequent enough to permit recording. Polysomnography usually documents REM and wake-dissociated states or REM and theta and occasional alpha rhythms (concomitant with rapid eye movements) associated with muscle atonia.
Management
In general, patients who frequently experience sleep paralysis learn that the episodes are brief and benign, with no significant aftermath. When episodes of sleep paralysis are infrequent, medical treatment is often unnecessary. An increased frequency of sleep paralysis also appears to lead to habituation and de-dramatization in some individuals (27).
Behavioral strategies in these cases are important and are used to prevent or disrupt isolated sleep paralysis (39). Techniques used to prevent them include sleep position or sleep patterns changes (staying up late, eliminating naps, and attaining a more regulated sleep routine), environment changes (increasing light/illumination, not sleeping in an enclosed space, decrease room’s temperature), resisting falling asleep/wake up, relaxation techniques, diet modification, caffeine use cessation, and stress reduction. Disrupting strategies include attempting to move extremities or other body parts, calling out, and calming down strategies (use of reassuring self-talk, trying to let go, regulating breathing, and the use of prayer during the episodes) (37). Cognitive behavioral therapy helps patients to learn some of these techniques or to cope with frightening hallucinations, discuss catastrophic thoughts, and resolve sleep paralysis episodes with imaginary rehearsal (39). A similar approach has been used with meditation relaxation (MR therapy), which includes four steps: reappraisal of the meaning of the attack, psychological and emotional distancing, inward focused-attention meditation, and muscle relaxation (22).
To reduce the negative emotions usually associated with sleep palsy, Herrero and colleagues proposed a new clinical approach for the treatment of recurrent sleep palsy, based on the recognition of auditory, tactile, and visual sensations preceding the episodes (18). When the patient recognizes these symptoms, he or she could try to induce out of body experiences that are usually associated with more positive emotions (happiness, love, peace, tranquility, hope, euphoria, and curiosity).
When these methods are not successful and when sleep paralysis occurs frequently enough to cause fear or anxiety about sleep, pharmacologic therapies can be considered. These therapies include drugs that modify the REM stage of sleep where sleep paralysis appears. These drugs are tricyclic antidepressants such as clomipramine (25 to 50 mg qd), imipramine (25 to 150 mg qd), protriptyline (10 to 40 mg), and desmethylimipramine (25 to 150 mg qd); selective serotonin reuptake inhibitors should also be taken into account such as fluoxetine (40 to 80 mg qd), paroxetine (25 mg qd), and escitalopram (10 mg qd) (39; 19). In narcolepsy there is an ongoing debate on the use of sodium oxybate, a GABAergic compound used to treat sleepiness and cataplexy in narcolepsy with cataplexy (12).
Outcomes
Usually, behavioral strategies are effective to prevent sleep paralysis. In a study on 156 undergraduates changes to sleeping patterns were advocated by subjects as being the most successful prevention technique (39). Meditation-relaxation therapy (MR therapy) showed promising results in subjects with isolated and recurrent sleep paralysis or in subjects with narcolepsy and sleep paralysis (21).
Unfortunately, the assessment of sleep paralysis and the particular nature of the outcome measures are either inconsistent across studies or not well defined (39).
Special considerations
Pregnancy
The prevalence of sleep paralysis decreases during the first trimester of pregnancy but increases during later pregnancy (from 5.7% to 13.3% in the second trimester), which is contrary to all of the other parasomnias (17). Sleep paralysis does not seem to affect pregnancy.
Anesthesia
Anesthesia does not seem to increase or reduce the frequency of sleep paralysis and is not contraindicated for patients with sleep paralysis. However, increased frequency of sleep paralysis after general anesthesia has been reported in narcolepsy, possibly related to drug withdrawal around surgery (20).
Media
References
- 01
- Aguirre C, Miranda M, Stefani A. Nikolai Gogol's account of sleep paralysis in the tale "The Portrait". Sleep Med 2021;85:317-20. PMID 34438188
- 02
- American Academy of Sleep Medicine. International classification of sleep disorders, 3rd edition, text revision. Darien, Illinois: American Academy of Sleep Medicine, 2023.**
- 03
- Benham G. Sleep paralysis in college students. J Am College Health 2020;1-6. PMID 32813623
- 04
- Blood C, Cacciatore J. “It started after trauma": the effects of traumatic grief on sleep paralysis. Omega (Westport) 2024;89(4):1451-72. PMID 35546322
- 05
- Buskova J, Piško J, Dostálová S, Růžička E, Sonka K. Incomplete sleep paralysis as the first symptom of narcolepsy. Sleep Med 2013;14(9):919-21. PMID 23746823
- 06
- Cerny F, Piorecká V, Kliková M, Koprivova J, Buskova J, Piorecky M. All-night spectral and microstate EEG analysis in patients with recurrent isolated sleep paralysis. Front Neurosci 2024. [Epub ahead of print] PMID 38389790
- 07
- Cheyne JA, Girard TA. The body unbound: vestibular-motor hallucinations and out-of-body experiences. Cortex 2009;45:201-15. PMID 18621363
- 08
- Colombo C, Cellini N. Lifetime prevalence and characteristics of sleep paralysis in Italian university students population. Sleep Med 2024; 122:106-12. PMID 39154571
- 09
- Cornejo-Sanchez DM, Carrizosa-Moog J, Cabrera-Hemer D, et al. Sleepwalking and sleep paralysis: prevalence in Colombian families with genetic generalized epilepsy. J Child Neurol 2019;34(9):491-8. PMID 31012364
- 10
- de Sà JF, Mota-Rolim SA. Sleep paralysis in Brazilian folklore and other cultures: a brief review. Front Psychol 2016;7:1294. PMID 27656151
- 11
- Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Med Rev 2018a;38:141-57.** PMID 28735779
- 12
- Denis D, French CC, Schneider MN, Gregory AM. Subjective sleep-related variables in those who have and have not experienced sleep paralysis. J Sleep Res 2018b;27(5):e12650. PMID 29280229
- 13
- Denis D, Poerio GL. Terror and bliss? Commonalities and distinctions between sleep paralysis, lucid dreaming, and their associations with waking life experiences. J Sleep Res 2017;26(1):38-47.** PMID 27460633
- 14
- Duarte JM, Lisi GR, Carroll BT, Garro MF, Appiani FJ. The prevalence of sleep paralysis in medical students in Buenos Aires, Argentina. J Neurosci Rural Pract 2023:272-5. PMID 37181188
- 15
- Farooq M, Anjum F. Sleep paralysis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021. PMID 32965993
- 16
- Golzari SE, Khodadoust K, Alakbarli F, et al. Sleep paralysis in medieval Persia - the Hidayat of Akhawayni (-983 AD). Neuropsychiatr Dis Treat 2012;8:229-34. PMID 22701323
- 17
- Hedman C, Pohjasvaara T, Tolonen U, Salmivaara A, Myllyla VV. Parasomnias decline during pregnancy. Acta Neurol Scand 2002;105:209-14. PMID 11886366
- 18
- Herrero NL, Gallo FT, Gasca-Rolín M, Gleiser PM, Forcato C. Spontaneous and induced out-of-body experiences during sleep paralysis: Emotions, "AURA" recognition, and clinical implications. J Sleep Res 2023;32(1):e13703. PMID 36053735
- 19
- Hintze JP, Gault D. Escitalopram for recurrent isolated sleep paralysis. J Sleep Res 2020;29:e13027. PMID 32112511
- 20
- Hu S, Singh M, Wong J, et al. Anesthetic management of narcolepsy patients during surgery: a systematic review. Anesth Analg 2018;126(1):233-46. PMID 29257771
- 21
- Jalal B, Romanelli A, Hinton DE. Sleep paralysis in Italy: frequency, hallucinatory experiences, and other features. Transcult Psychiatry 2020a;58(3):427-39. PMID 32233744
- 22
- Jalal B, Moruzzi L, Zangrandi A, et al. Meditation-relaxation (MR therapy) for sleep paralysis: a pilot study in patients with narcolepsy. Front Neurol 2020b;11:922. PMID 32903364
- 23
- Kliková M, Sharpless BA, Bušková J. Could sleep paralysis be pleasant? J Sleep Res 2020;31(3):e13154. PMID 32869388
- 24
- Kompanje EJ. 'The devil lay upon her and held her down'. Hypnagogic hallucinations and sleep paralysis described by the Dutch physician Isbrand van Diemerbroeck (1609-1674) in 1664. J Sleep Res 2008;17:464-7. PMID 18691361
- 25
- Kotorii T, Kotorii T, Uchimura N, et al. Questionnaire relating to sleep paralysis. Psychiatry Clin Neurosci 2001;55:265-6. PMID 11422869
- 26
- Mainieri G, Maranci J-B, Champetier P, et al. Are sleep paralysis and false awakenings different from REM sleep and from lucid REM sleep? A spectral EEG analysis. J Clin Sleep Med 2021;17(4):719-27.** PMID 33283752
- 27
- Mayer G, Fuhrmann M. A German online survey of people who have experienced sleep paralysis. J Sleep Res 2022;31(3):e13509. PMID 34676599
- 28
- Miletinova E, Kliková M, Dostalíková A, Bušková J. Morphological characteristics of cerebellum, pons and thalamus in recurrent isolated sleep paralysis - a pilot study. Front Neuroanat 2024;18:1396829. PMID 38962392
- 29
- Miranda M, Högl B. Guy de Maupassant and his account of sleep paralysis in his tale, "The Horla". Sleep Med 2013;14(6):578-80. PMID 23660121
- 30
- Mitchell SW. On some of the disorders of sleep. Virginia Med Monthly 1876;2:769-81.
- 31
- Molendijk ML, Montagne H, Bouachmir O, Alper Z, Bervoets JP, Blom JD. Prevalence rates of the incubus phenomenon: a systematic review and meta-analysis. Front Psychiatry 2017;8:253. PMID 29225584
- 32
- Muzammil MA, Syed AR, Farooq MH, et al. Frequency and factors of sleep paralysis among medical students of Karachi. Cureus 2023;15(7):e41722. PMID 37575779
- 33
- Ohayon MM, Pakpour AH. Prevalence, incidence, evolution and associated factors of sleep paralysis in a longitudinal study of the US general population. Sleep Med 2022;98:62-7. PMID 35785587
- 34
- Ohayon MM, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999;52:1194-200.** PMID 10214743
- 35
- Olunu E, Kimo R, Onigbinde EO, et al. Sleep paralysis, a medical condition with a diverse cultural interpretation. Int J Appl Basic Med Res 2018;8(3):137-42. PMID 30123741
- 36
- Pizza F, Moghadam KK, Franceschini C, et al. Rhythmic movements and sleep paralysis in narcolepsy with cataplexy: a video-polygraphic study. Sleep Med 2010;11(4):423-5.** PMID 20199889
- 37
- Rauf B, Sharpless BA, Denis D, et al. Isolated sleep paralysis: Clinical features, perception of aetiology, prevention and disruption strategies in a large international sample. Sleep Med 2023;104:105-12. PMID 36934464
- 38
- Rocca FL, Pizza F, Ricci E, Plazzi G. Narcolepsy during childhood: an update. Neuropediatrics 2015;46(3):181-98. PMID 25961600
- 39
- Sharpless BA. A clinician’s guide to recurrent isolated sleep paralysis. Neuropsych Dis Treat 2016;12:1761-7. PMID 27486325
- 40
- Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: A systematic review. Sleep Med Rev 2011;15(5):311-5. PMID 21571556
- 41
- Sharpless BA, Grom JL. Isolated sleep paralysis: fear, prevention, and disruption. Behav Sleep Med 2016;14(2):134-9. PMID 25315810
- 42
- Sharpless BA, Kliková M. Clinical features of isolated sleep paralysis. Sleep Med 2019;58:102-6. PMID 31141762
- 43
- Stefani A, Iranzo A, Santamaria J, Högl B; SINBAR (Sleep Innsbruck Barcelona) group. Description of sleep paralysis in The Brothers Karamazov by Dostoevsky. Sleep Med 2017;32:198-200. PMID 28366334
- 44
- Takeuchi T, Miyasita A, Sasaki Y, Inugami M, Fukuda K. Isolated sleep paralysis elicited by sleep interruption. Sleep 1992;15(3):217-25.** PMID 1621022
- 45
- Terzaghi M, Ratti PL, Manni F, Manni R. Sleep paralysis in narcolepsy: more than just a motor dissociative phenomenon. Neurol Sci 2012;33(1):169-72.** PMID 21647627
- 46
- Vetrugno R, Vella A, Mascalchi M, et al. Peduncular hallucinosis: a polysomnographic and SPECT study of a patient and efficacy of serotonergic therapy. Sleep Med 2009;10(10):1158-60. PMID 19592304
- 47
- Wing YK, Lee ST, Chen CN. Sleep paralysis in Chinese: ghost oppression phenomenon in Hong Kong. Sleep 1994;17:609-13. PMID 7846458
- 48
- Wróbel-Knybel P, Flis M, Rog J, Jalal B, Wołkowski L, Karakuła-Juchnowicz H. Characteristics of sleep paralysis and its association with anxiety symptoms, perceived stress, PTSD, and other variables related to lifestyle in selected high stress exposed professions. Int J Environ Res Public Health 2022;19(13):7821. PMID 35805480
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Author
-
Giuseppe Loddo MD
Dr. Loddo of AUSL Bologna received a consultant honorarium from Bruno Pharmaceutica and a congress registration fee from B2 Pharma.
See Profile
Editor
-
Federica Provini MD
Dr. Provini of the University of Bologna and IRCCS Institute of Neurological Sciences of Bologna received speakers' fees from Idorsia, Italfarmaco, and NeoPharmed Gentili Spa.
See Profile
Former Authors
- Yasuo Hishikawa MD
- Pasquale Montagna MD
- Fabio Pizza MD PhD
Patient Profile
- Age range of presentation
-
- 2 to 65+ years
- Sex preponderance
-
- female=male
- Heredity
-
- heredity may be a factor
- Population groups selectively affected
-
- African Americans
- Occupation groups selectively affected
-
- Night-shift workers
ICD & OMIM codes
- ICD-10
-
- Narcolepsy and cataplexy: G47.4
- Other sleep disorders: G47.8
- ICD-11
-
- Recurrent isolated sleep paralysis: 7B01.1
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Sleep Disorders
NonREM parasomnias
Dec. 01, 2024
-
General Neurology
Neurologic disorders associated with obesity
Nov. 09, 2024
-
Sleep Disorders
Hypersomnolence
Nov. 04, 2024
-
Sleep Disorders
Sleep disorders in women
Oct. 27, 2024
-
Sleep Disorders
Sleep, stroke, and vascular dementia
Oct. 14, 2024
-
Sleep Disorders
Parasomnia overlap disorder and status dissociatus
Oct. 14, 2024
-
Sleep Disorders
Stimulant-dependent sleep disorder
Oct. 05, 2024